1st Quarter - Report

NOSSAMAN LLP for AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP")

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

H.R.1392 and S.1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R.4872, Health Care and Education Reconciliation Act of 2010. H.R.3590, Patient Protection and Affordable Care Act.

LobbyistCovered position, as disclosed
BRENT HEBERLEE Legislative Director, Senator Richard Bryan
TIMOTHY W JENKINS —
SHERRY HARPER WIDICUS Legislative Director, Congressman Ron Kind

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1392 (111th), H.R. 3590 (111th), S. 1221 (111th), H.R. 4872 (111th)

Medicare/Medicaid MMM

H.R.1392 and S.1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R.4872, Health Care and Education Reconciliation Act of 2010. H.R.3590, Patient Protection and Affordable Care Act.

LobbyistCovered position, as disclosed
BRENT HEBERLEE Legislative Director, Senator Richard Bryan
TIMOTHY W JENKINS —
SHERRY HARPER WIDICUS Legislative Director, Congressman Ron Kind

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4872 (111th), H.R. 3590 (111th), H.R. 1392 (111th), S. 1221 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.